J. Pesa

发表

Serious Mental Illness and Health-Related Factors Associated with Regional Emergency Department Utilization.

K. Azar, C. Nasrallah, A. Pressman, 2019, Population health management.

The Medical Costs of Migraine and Comorbid Anxiety and Depression

M. Lage, J. Pesa, 2004, Headache.

Opioid utilization patterns among medicare patients with diabetic peripheral neuropathy.

S. Mody, J. Pesa, R. Meyer, 2013, American health & drug benefits.

Factors associated with COVID-19 Infection among a national population of individuals with schizophrenia or schizoaffective disorder in the United States

J. Liberman, C. Ruetsch, J. Pesa, 2022, BMC Psychiatry.

Improving diversity in study participation: Patient perspectives on barriers, racial differences and the role of communities

J. Pesa, Lisa Shea, Gabrielle Geonnotti, 2022, Health expectations : an international journal of public participation in health care and health policy.

Psychosocial factors associated with dieting behaviors among female adolescents.

J. Pesa, 1999, The Journal of school health.

Health-enhancing behaviors correlated with breastfeeding among a national sample of mothers.

J. Pesa, M. Shelton, M. Shelton, 1999, Public health nursing.

Pmh5 Rehospitalization After Discontinuation of Paliperidone Er in Patients With Schizophrenia

J. Pesa, L. Mao, J. Wu, 2008 .

Fruit and vegetable intake and weight-control behaviors among US youth.

J. Pesa, L. W. Turner, 2001, American journal of health behavior.

Factors Associated with COVID-19 Infection among a National Population of Individuals with Schizophrenia in the United States

J. Liberman, C. Ruetsch, J. Pesa, 2022 .

The association between smoking and unhealthy behaviors among a national sample of Mexican-American adolescents.

J. Pesa, 1998, The Journal of school health.

Relationship between initial quetiapine dose and effectiveness as reflected in subsequent mental health service use among patients with schizophrenia or bipolar disorder.

F. Gianfrancesco, Ruey-hua Wang, J. Pesa, 2005, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.

Psychosocial differences associated with body weight among female adolescents: the importance of body image.

J. Pesa, E. Jones, T. Syre, 2000, The Journal of adolescent health : official publication of the Society for Adolescent Medicine.

Implementing universal suicide screening in a large healthcare system's hospitals: rates of screening, suicide risk, and documentation of subsequent psychiatric care.

Anna J. Kiger, K. Azar, J. Pesa, 2023, Translational behavioral medicine.

Neo-Adjuvant chemotherapy in cervical cancer stage IIB ; PEC + RT vs RT. Preliminary results

J. Pesa, A. Olguin, J. Cardenas, 1991 .

Assessment of antipsychotic-related risk of diabetes mellitus in a Medicaid psychosis population: sensitivity to study design.

H. Nasrallah, F. Gianfrancesco, Ruey-hua Wang, 2006, American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists.

Applying the Health Belief Model to Characterize Racial/Ethnic Differences in Digital Conversations Related to Depression Pre- and Mid-COVID-19: Descriptive Analysis

R. Castilla-Puentes, J. Pesa, Caroline Brethenoux, 2021, JMIR formative research.

United States national trends in prevalence of major depressive episode and co-occurring suicidal ideation and treatment resistance among adults

S. Wilkinson, J. Sheehan, J. Pesa, 2021, Journal of Affective Disorders Reports.

Follow-up Care among Medicaid Patients with Schizophrenia treated with Antipsychotics in the Inpatient Setting

David M. Smith, A. Farr, J. Pesa, 2014 .

One-year clinical and economic consequences of oral atypical antipsychotics in the treatment of schizophrenia*

R. Dirani, D. Meletiche, J. Pesa, 2008 .

Hospitalisation risks in the treatment of schizophrenia in a Medicaid population: comparison of antipsychotic medications

K. Rajagopalan, F. Gianfrancesco, J. Pesa, 2006, International journal of clinical practice.

Costs and Resource Utilization Among Medicaid Patients with Schizophrenia Treated with Paliperidone Palmitate or Oral Atypical Antipsychotics

David M. Smith, E. Muser, J. Pesa, 2015, Drugs - Real World Outcomes.

Healthcare resource utilization and costs before and after long-acting injectable antipsychotic initiation in commercially insured young adults with schizophrenia

A. Fu, J. Pesa, C. Benson, 2022, BMC Psychiatry.

Depression and food insecurity among patients with rheumatoid arthritis in NHANES

A. Fu, J. Pesa, Q. Cai, 2022, BMC Rheumatology.

Assessing quality of life in women living with HIV infection

J. Pesa, J. Cowdery, 2002, AIDS care.

Development of a patient decision aid for treatment resistant depression.

R. Shelton, S. Langenecker, A. Shillington, 2020, Journal of affective disorders.

Measuring satisfaction with migraine treatment: expectations, importance, outcomes, and global ratings.

D. Patrick, Mona L. Martin, D. Bushnell, 2003, Clinical therapeutics.

Comparison of Real-world Outcomes Between Patients Treated with Tapentadol ER or Oxycodone CR

J. Pesa, R. Halpern, M. Durkin, 2015, Journal of health economics and outcomes research.

Comparison of mental health resources used by patients with bipolar disorder treated with risperidone, olanzapine, or quetiapine.

F. Gianfrancesco, Ruey-hua Wang, J. Pesa, 2005, Journal of managed care pharmacy : JMCP.

Comparison of Mental Health Resources Used by Patients With Bipolar Disorder Treated With Risperidone, Olanzapine, or Quetiapine

F. Gianfrancesco, Ruey-hua Wang, J. Pesa, 2005, Journal of managed care pharmacy : JMCP.

Health care resource utilization and costs of California Medicaid patients with schizophrenia treated with paliperidone palmitate once monthly or atypical oral antipsychotic treatment

O. Baser, Li Wang, J. Pesa, 2017, Current medical research and opinion.

Factors Associated with Adherence to the HEDIS Quality Measure in Medicaid Patients with Schizophrenia.

J. Fastenau, M. Duh, P. Lefebvre, 2016, American health & drug benefits.

Relationship Between Medicaid Eligibility And Time To Re-Incarceration Of Previously Incarcerated Subjects With Schizophrenia

M. Dickson, C. Kozma, J. Pesa, 2014 .

Predicting Poor Outcomes Among Individuals Seeking Care for Major Depressive Disorder

J. Liberman, B. Ahmedani, J. Pesa, 2022, Psychiatric research and clinical practice.

Social determinants and distance from certified treatment centers are associated with initiation of esketamine nasal spray among patients with challenging-to-treat major depressive disorder

L. Harding, J. Pesa, Pinyao Rui, 2023, Medicine.

The Impact of Medicaid Preferred Drug Lists on Utilization and Costs of Antipsychotic Medication

J. Fastenau, J. Pesa, C. Frois, 2013, Journal of health economics and outcomes research.

Factors associated with patient activation among individuals with depression within racial/ethnic groups in the United States

J. Pesa, M. Cambron-Mellott, N. Way, 2023, Preventive medicine reports.

Applying the Health Belief Model to Characterize Racial/Ethnic Differences in Digital Conversations Related to Depression Pre– and Mid–COVID-19 (Preprint)

R. Castilla-Puentes, T. Falcone, J. Pesa, 2021 .

Impact of paliperidone palmitate versus oral atypical antipsychotics on healthcare outcomes in schizophrenia patients.

Yongling Xiao, E. Muser, J. Fastenau, 2015, Journal of comparative effectiveness research.

Healthcare utilization and costs of veterans health administration patients with schizophrenia treated with paliperidone palmitate long-acting injection or oral atypical antipsychotics

O. Baser, J. Pesa, M. Durkin, 2015, Journal of medical economics.

Sex differences in barriers to contraceptive use among adolescents.

J. Pesa, L. Turner, L. W. Turner, 2001, The Journal of pediatrics.

Self-Reported Depression and Risk-Taking Behaviors among Hispanic Adolescents

J. Cowdery, J. Pesa, M. Wang, 1997, Psychological reports.

An evaluation of the impact of patient cost sharing for antihypertensive medications on adherence, medication and health care utilization, and expenditures

R. McQueen, K. Nair, J. Saseen, 2012, Patient preference and adherence.

Risk Factors, Health Care Resource Utilization, and Costs Associated with Nonadherence to Antiretrovirals in Medicaid-Insured Patients with HIV

P. Lefebvre, J. Pesa, N. Tandon, 2018, Journal of managed care & specialty pharmacy.

Opioid analgesic-treated chronic pain patients at risk for problematic use.

J. Volpicelli, C. Ruetsch, L. Vo, 2013, The American journal of managed care.

The association between heart failure hospitalization and self-reported domains of health

G. Nichols, J. Pesa, Aarti A Patel, 2019, Quality of Life Research.

Factors Associated with Diabetes-Related Clinical Inertia in a Managed Care Population and Its Effect on Hemoglobin A1c Goal Attainment: A Claims-Based Analysis.

C. McAdam-Marx, B. Bellows, R. Bailey, 2019, Journal of managed care & specialty pharmacy.

Medicaid Eligibility and Time to Re-incarceration Among Previously Incarcerated Subjects With Schizophrenia

M. Dickson, C. Kozma, J. Pesa, 2016, Journal of health economics and outcomes research.

Understanding the Relationship Between Depression Symptom Severity and Health Care Costs for Patients With Treatment-Resistant Depression.

F. Lynch, J. Dickerson, M. O'Keeffe-Rosetti, 2022, Journal of Clinical Psychiatry.

Economic burden to commercial payers of young adults with schizophrenia in Colorado

R. Potluri, J. Pesa, C. Benson, 2021, Journal of medical economics.

Mental Health Care Resource Utilization and Barriers to Receiving Mental Health Services Among US Adults With a Major Depressive Episode and Suicidal Ideation or Behavior With Intent.

S. Wilkinson, J. Sheehan, J. Pesa, 2021, The Journal of clinical psychiatry.

Effect of antihypertensive medication adherence among employees with hypertension.

W. Lynch, J. Pesa, N. Kleinman, 2009, The American journal of managed care.

Real-world analysis of insurance churn among young adults with schizophrenia using the Colorado All-Payer Claims Database

R. Potluri, J. Pesa, C. Benson, 2022, Journal of managed care & specialty pharmacy.

One-year clinical and economic consequences of oral atypical antipsychotics in the treatment of schizophrenia.

R. Dirani, D. Meletiche, J. Pesa, 2008, Current medical research and opinion.